| # | Side effect | Count |
|---|---|---|
| 0 | NEUROMYELITIS OPTICA SPECTRUM DISORDER | 130 |
| 1 | OFF LABEL USE | 76 |
| 2 | HEADACHE | 50 |
| 3 | URINARY TRACT INFECTION | 44 |
| 4 | FATIGUE | 39 |
| 5 | NAUSEA | 38 |
| 6 | MYASTHENIA GRAVIS | 37 |
| 7 | PNEUMONIA | 36 |
| 8 | COVID-19 | 32 |
| 9 | PAIN | 31 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | NEUROMYELITIS OPTICA SPECTRUM DISORDER | 130 | 0.0964 |
| 1 | BLOOD OSMOLARITY | 1 | 0.0556 |
| 2 | IMMUNOGLOBULIN G4 RELATED DISEASE | 12 | 0.0376 |
| 3 | COSTAL CARTILAGE FRACTURE | 1 | 0.0294 |
| 4 | HEPATITIS E ANTIBODY POSITIVE | 1 | 0.0286 |
| 5 | POST-DEPLETION B-CELL RECOVERY | 3 | 0.0263 |
| 6 | CUTIBACTERIUM ACNES INFECTION | 1 | 0.0169 |
| 7 | BLOOD COPPER DECREASED | 1 | 0.0122 |
| 8 | B-LYMPHOCYTE COUNT INCREASED | 2 | 0.0108 |
| 9 | ATYPICAL MYCOBACTERIUM TEST POSITIVE | 1 | 0.0103 |